Loading clinical trials...
Loading clinical trials...
A Double-Blind, Placebo-Controlled, Cross-over Trial, Evaluating Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
Conditions
Interventions
Dasiglucagon
Dasiglucagon
+1 more
Start Date
February 1, 2023
Primary Completion Date
February 1, 2023
Completion Date
February 1, 2023
Last Updated
February 21, 2023
NCT03970720
NCT04786262
NCT00001276
NCT06993103
NCT06643351
NCT07217483
Lead Sponsor
Zealand Pharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions